Stephen Saad’s stake in Africa’s largest pharmaceutical company sinks below $600 million
South African pharmaceutical tycoon Stephen Saad faces setback as Aspen Pharmacare shares decline.
Related
Stephen Saad’s stake in Aspen slips below $450 million
South African pharma tycoon Stephen Saad’s stake in Aspen Pharmacare drops to $434.35 million, losing $62.85 million in 15 days.
Stephen Saad’s wealth takes a hit as Aspen Pharmacare stock plunges, erasing $41 million
This downturn follows a $44 million gain in January, which had lifted his stake to R10.26 billion ($550.1 million).
Stephen Saad leads Africa’s largest drugmaker to $1.2 billion in half-year revenue
The growth was fueled by the successful integration of acquired products in Latin America.
Africa’s largest asset manager buys additional stake worth $67 million in Stephen Saad’s Aspen Pharmacare
With this latest transaction, PIC’s stake in Aspen is now worth nearly a billion dollars—R15.2 billion ($824.24 million).
Latest
Hend El-Sherbini loses $19.5 million from IDH shares
Hend El-Sherbini is one of Egypt’s leading executives and a key figure in the MENA region’s healthcare sector.
Motsepe donates $10 million to support youth sports, education in Africa
The donation highlights his commitment to youth empowerment through sport and education across Africa.
Trevor Noah backs Stitch's latest $55 million funding round
Noah’s involvement as an angel investor is a testament to the growing overlap between Africa’s creative talent and the global tech investment scene.
Michiel le Roux gains nearly $300 million from Capitec stake
This follows a recent rally in the share price of the retail banking giant on the Johannesburg Stock Exchange (JSE).